Drug Index


Mechanism :

Its antiemetic activity may be due to effect on cannabinoid receptors (CB1) within the central nervous system.

Indication :

  • Treatment of refractory nausea and vomiting associated with cancer chemotherapy

Contraindications :

Hypersensitivity to nabilone, other cannabinoids, or any component of the formulation.

Dosing :

<18 kg
0.5 mg every 12 hours.
18 to 30 kg
1 mg every 12 hours.
>30 kg
1 mg every 8 to 12 hours.
Maximum dose: 0.06 mg/kg/day.

Adverse Effect :

Drowsiness, dizziness, vertigo, euphoria, ataxia, depression, lack of concentration, sleep disturbance, xerostomia, visual disturbance, hypotension, dysphoria, headache, sedation, anorexia, nausea, weakness.

Interaction :

Anticholinergic Agents: May enhance the tachycardic effect of Cannabinoid-Containing Products.
Blood Pressure Lowering Agents: May enhance the hypotensive effect of Hypotension-Associated Agents.
CNS Depressants: Nabilone may enhance the CNS depressant effect of CNS Depressants.
Sympathomimetics: Cannabinoid-Containing Products may enhance the tachycardic effect of Sympathomimetics.

Hepatic Dose :

No dose adjustments are recommended. It is extensively metabolized by the liver, hence use caution when initiating or adjusting nabilone dosage.
01/24/2024 19:36:25 Nabilone
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0